Navigation Links
Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance
Date:2/3/2009

Oncotype DX and advance our pipeline, while continuing to move the organization toward profitability," said Brad Cole, Chief Operating and Financial Officer of Genomic Health. "To achieve these goals, we expect that the majority of our anticipated annual net loss will be realized in the first half of the year as we continue to invest in our product pipeline, U.S. sales force expansion and worldwide commercial infrastructure."

The Company is providing the following financial guidance for the full year ending December 31, 2009:

    -- Test results delivered of 50,000 to 53,000
    -- Revenue of $148 million to $160 million
    -- Net loss of $7 million to $14 million


    Recent Highlights and Accomplishments

    Commercial Progress

    -- More than 39,600 test results delivered for the full year of 2008, an
       increase of 62 percent, compared with 24,450 test results delivered in
       2007.  In the fourth quarter of 2008 more than 10,580 test results were
       delivered, an increase of 47 percent, compared with more than 7,200
       test results delivered in the same period in 2007.
    -- More than 85,000 Oncotype DX test results have been delivered as of
       December 31, 2008.
    -- In 2008, gained coverage through contracts, policies and agreements for
       an additional 56 million U.S. lives for the Oncotype DX breast cancer
       assay, bringing the total U.S. lives covered to more than 90 percent
       for appropriate node-negative breast cancer patients.
    -- Established a contract with the Blue Cross Blue Shield (BCBS)
       Association, which we believe will lead to additional coverage with
       non-contracted BCBS plans.
    -- Oncotype DX remains the only multi-gene expression assay to be
       recommended by both the National Comprehensive Cancer Network (NCCN)
       and American Society of Clinical Oncology (ASCO) in their respective
       Breast Cancer Treatment Gui
'/>"/>
SOURCE Genomic Health
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Enrichment of Genomic Loci for Targeted Sequencing Application Is Focus of 2009 AGBT Conference Workshop
2. Complete Genomics to Release Its DNA Sequencing Data for the First Time at Advances in Genome Biology and Technology Annual Meeting
3. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
4. Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum
5. Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay
6. Sirius Genomics Announces New Collaboration with UK Critical Care Genomics Group
7. Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.
8. AutoGenomics Invited to Present at the 2009 JPMorgan Healthcare Conference
9. Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso
10. Transgenomic Receives Accreditation From College of American Pathologists
11. Genomic Health Announces Appointment of Ginger Graham to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015  Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, today announced that executives ... in the month of September.  , ... at Rodman & Renshaw,s 17th Annual Global Investment Conference ... at the St. Regis Hotel in New ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... needs and expertly narrows down the product choices to a manageable shortlist of ... down the list to models that fit best with the customer’s industry and ...
(Date:8/26/2015)... 2015  Roka Bioscience, Inc. (NASDAQ: ROKA ), ... solutions for the detection of foodborne pathogens, today announced ... Sidoti & Company Emerging Growth Conference on September 2 ... the New York Marriott Marquis. A ... the investor relations section of Roka Bioscience,s website at ...
(Date:8/26/2015)... , August 26, 2015 Israel Proves ... DiaCardio wins 1 st place  Wayerz comes in ... Israel by venture capital fund JVP, with ... the US, China , Israel ... .  Impressive achievement for the Israeli representatives in ...
Breaking Biology Technology:Asterias Biotherapeutics to Present at Upcoming Investor Conferences 2METTLER TOLEDO Updates Online Scale Selection Tool 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6
... COATED PLATE ASSAYS ... instrument for the counting of radioimmunoassays based on coated microtitration plates. The ... data presented compare the standard immunoassay microtitration plates with those manufactured by ... basic assay procedure is straightforward: , ...
... Introduction , ... brain can lead to several disease states, including anxiety, depression ... the mode of action of various transmitters, in order to ... the neurotransmitter to its receptor alters the production of the ...
... J. Watson , ... Introduction , ... resulted in an increase in the production of potential drug candidates, it ... PerkinElmer Life Sciences has provided a platform for the adaptation of a ...
Cached Biology Technology:Coated Plate Immunoassay on the MicroBeta - eg. TSH - IRMA 2In Vitro Measurement of the Second Messenger cAMP: RIA vs. FlashPlate 2In Vitro Measurement of the Second Messenger cAMP: RIA vs. FlashPlate 3In Vitro Measurement of the Second Messenger cAMP: RIA vs. FlashPlate 4Use of Novel FlashPlate Technology to Measure cAMP Accumulation in Chinese Hamster Ovary Cells Expressing Human -2 Adrenoreceptors 2Use of Novel FlashPlate Technology to Measure cAMP Accumulation in Chinese Hamster Ovary Cells Expressing Human -2 Adrenoreceptors 3Use of Novel FlashPlate Technology to Measure cAMP Accumulation in Chinese Hamster Ovary Cells Expressing Human -2 Adrenoreceptors 4
(Date:8/25/2015)... BELLEVUE, Wash. , Aug. 25, 2015  Sarcos ... today it will unveil its "Guardian S" snake robot, ... National Tactical Officers Association Conference on August 30 in ... is the first-ever commercially available energetically autonomous snake robot, ... in-field trials and is protected by more than 50 ...
(Date:8/20/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market and creator of the Wocket® ... Alliance and the EMV Migration Forum.  ... Alliance Latin America (SCALA) Chapter provides NXT-ID, Inc. direct ... promoting adoption of smart card technology. To ...
(Date:8/12/2015)... Minn. , Aug. 12, 2015   MedNet ... supports the entire spectrum of clinical research, is proud ... , the company,s comprehensive SaaS-based eClinical technology platform, has ... during the first two quarters of 2015.   Q2 ... second largest quarters measured by contract value sold in ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2
... Reseachers at The Ohio State University have demonstrated that ... method for preserving the important genetic diversity of ornamental ... some of the most popular flowers the world. So ... more than 3,000 varieties of geranium in their 2004 ...
... of scientists today in an advanced online publication in the ... background of the type of lung cancer that is the ... Of particular interest was a specific proto-oncogene called NKX2-1 ... lung adenocarcinomas the most common cause of cancer ...
... Northeast Biofuel Summit, Nov. 11-13, at the Statler Hotel ... regions current biomass inventory, including agricultural feedstock designated for ... to diversify and expand biofuel feedstocks (those plants which ... participants will assess the Northeasts ability to meet its ...
Cached Biology News:'TRAP' preserves genetic properties of popular geranium 2Tumor genome analysis unveils new insights into lung cancer 2Tumor genome analysis unveils new insights into lung cancer 3
...
Request Info...
Human RUNX2/CBFA1 MAb (Clone 232902)...
... Streptavidin-Horseradish Peroxidase Conjugate, 2 ... reporter enzyme molecules for ... in situ hybridization applications.High ... & Labeling & Detection, ...
Biology Products: